Carcinogenic human papillomavirus infection

M Schiffman, J Doorbar, N Wentzensen… - Nature reviews Disease …, 2016 - nature.com
Infections with human papillomavirus (HPV) are common and transmitted by direct contact.
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …

[HTML][HTML] Cervical cancer in low and middle‑income countries

R Hull, M Mbele, T Makhafola, C Hicks… - Oncology …, 2020 - spandidos-publications.com
Cervical cancer is a malignant tumour that occurs in the cervix and is classified into two
histological types, adenocarcinoma and squamous cell carcinoma (SCC); SCC is more …

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

ETH Fontham, AMD Wolf, TR Church… - CA: a cancer journal …, 2020 - Wiley Online Library
Abstract The American Cancer Society (ACS) recommends that individuals with a cervix
initiate cervical cancer screening at age 25 years and undergo primary human …

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women

EA Joura, AR Giuliano, OE Iversen… - … England Journal of …, 2015 - Mass Medical Soc
Background The investigational 9-valent viruslike particle vaccine against human
papillomavirus (HPV) includes the HPV types in the quadrivalent HPV (qHPV) vaccine (6 …

[HTML][HTML] Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)

LE Markowitz, EF Dunne, M Saraiya, HW Chesson… - MMWR Recomm …, 2014 - cdc.gov
This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Epidemiology and burden of HPV-related disease

B Serrano, M Brotons, FX Bosch, L Bruni - Best practice & research Clinical …, 2018 - Elsevier
Human papillomavirus (HPV) infection is recognized as one of the major causes of infection-
related cancer in both men and women. High-risk HPV types are not only responsible for …

Penile cancer

A Thomas, A Necchi, A Muneer… - Nature Reviews …, 2021 - nature.com
Penile squamous cell carcinoma (PSCC) is a rare cancer with orphan disease designation
and a prevalence of 0.1–1 per 100,000 men in high-income countries, but it constitutes up to …

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

Immunology and immunotherapy of head and neck cancer

RL Ferris - Journal of clinical oncology, 2015 - ascopubs.org
The immune system plays a key role in the development, establishment, and progression of
head and neck squamous cell carcinoma (HNSCC). A greater understanding of the …

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

WK Huh, EA Joura, AR Giuliano, OE Iversen… - The Lancet, 2017 - thelancet.com
Background Primary analyses of a study in young women aged 16–26 years showed
efficacy of the nine-valent human papillomavirus (9vHPV; HPV 6, 11, 16, 18, 31, 33, 45, 52 …